Key result
Indole derivatives protect against doxorubicin-induced myocardial damage through multiple mechanisms, including antioxidant activity, mitochondrial protection, and apoptosis suppression.
Why the study?
Doxorubicin is a first-line cancer chemotherapy drug, but severe myocardial toxicity limits its widespread use.
Do indole derivatives protect against doxorubicin-induced cardiomyopathy?
Do indole derivatives protect against doxorubicin-induced cardiomyopathy?
Indole derivatives show potential as protective agents against doxorubicin-induced cardiomyopathy through multiple molecular mechanisms.
Does not support clinical use of indole derivatives; leaves open their role in doxorubicin cardioprotection pending human trials.
BACKGROUND: Doxorubicin is a first-line drug used in cancer chemotherapy, but its severe myocardial toxicity limits its widespread use. Indole derivatives, a large class of substances widely found in natural plants and metabolic products, exhibit a variety of biological effects. SUMMARY: Previous studies have shown that indole compounds can protect against doxorubicin-induced myocardial damage through multiple mechanisms, including antioxidant activity, mitochondrial protection, anti-inflammatory effects, ferroptosis inhibition, apoptosis suppression, and endoplasmic reticulum stress attenuation. Understanding the pathogenesis of doxorubicin-induced cardiomyopathy and the molecular mechanisms by which indole compounds protect the myocardium is crucial for the development of novel drug molecules based on indole compounds in the future. KEY MESSAGES: Focusing on the molecular characteristics of indole derivatives, investigating their pharmacodynamics and safety, and developing safe and effective antagonistic molecules to counteract doxorubicin toxicity, holds great potential, and significance.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) conducted a review in Doxorubicin-Induced Cardiomyopathy. Indole derivatives was evaluated. Indole derivatives protect against doxorubicin-induced myocardial damage through multiple mechanisms, including antioxidant activity, mitochondrial protection, and apoptosis suppression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: